Company
Sanofi returns to CIIE with increased focus in type 1 diabetes
Sanofi showcases the innovative treatment Tzield, the world's first and only disease modifying therapy to delay the onset of type 1 diabetes and preserve beta-cell function.
2024-11-09 22:17